William E. Evans
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism 33
- Hematology top 0.05%
- Acute Myeloid Leukemia Research 35
- Chronic Myeloid Leukemia Treatments 26
-
- Childhood Cancer Survivors' Quality of Life 109
- Pharmaceutical studies and practices 35
-
- Acute Lymphoblastic Leukemia research 212
- Oncology top 0.2%
-
- Cancer therapeutics and mechanisms 31
-
- Adolescent and Pediatric Healthcare 20
- Co-authors
- Mary V. RellingChing‐Hon PuiHoward L. McLeodEugene Y. KrynetskiGaston K. RiveraJohn T. SandlundRaul C. RibeiroWenjian Yang
- Journals
- Blood (51 papers)Journal of Clinical Oncology (30 papers)Clinical Pharmacology & Therapeutics (28 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
William E. Evans
370 papers receiving 33.0k citations
Hit Papers
Peers
Comparison fields: 5 of 195
- Pharmacology 5.8k
- Hematology 7.4k
- Pediatrics, Perinatology and Child Health 11.3k
- Public Health, Environmental and Occupational Health 15.6k
- Oncology 6.7k
Countries citing papers authored by William E. Evans
This map shows the geographic impact of William E. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Evans more than expected).
Fields of papers citing papers by William E. Evans
This network shows the impact of papers produced by William E. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Evans. The network helps show where William E. Evans may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William E. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2021 | 4 | |
| 3 | 2021 | 10 | |
| 4 | 2020 | 14 | |
| 5 | 2020 | 20 | |
| 6 | 2019 | 21 | |
| 7 | 2018 | 254 | |
| 8 | Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on | 2018 | 403 |
| 9 | 2014 | 242 | |
| 10 | 2014 | 165 | |
| 11 | 2014 | 152 | |
| 12 | 2013 | 187 | |
| 13 | 2012 | 157 | |
| 14 | 2010 | 186 | |
| 15 | 2008 | 116 | |
| 16 | 2005 | 109 | |
| 17 | 2005 | 13 | |
| 18 | 2001 | 2 | |
| 19 | 1993 | 47 | |
| 20 | 1989 | 29 |
About William E. Evans
William E. Evans is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Hematology, having authored 386 papers that have together received 34.0k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (212 papers), Childhood Cancer Survivors' Quality of Life (109 papers), Acute Myeloid Leukemia Research (35 papers), Pharmaceutical studies and practices (35 papers), Pharmacogenetics and Drug Metabolism (33 papers), Cancer therapeutics and mechanisms (31 papers), Chronic Myeloid Leukemia Treatments (26 papers) and Adolescent and Pediatric Healthcare (20 papers). The work is most often cited by research in Pharmacology (5.8k citations), Hematology (7.4k citations) and Pediatrics, Perinatology and Child Health (11.3k citations). William E. Evans has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Mary V. Relling, Ching‐Hon Pui, Howard L. McLeod, Eugene Y. Krynetski, Gaston K. Rivera, John T. Sandlund, Raul C. Ribeiro, Wenjian Yang, Cheng Cheng and James R. Downing. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, New England Journal of Medicine and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.